Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and Bevacizumab Maintenance in Advanced Colorectal Cancer
NCT01057017Phase 2Terminated
- Sponsor
- Brown University
- Start
- Jan 2010
- Primary completion
- Apr 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (CRC), sponsored by Brown University. Started Jan 2010; status: terminated.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01057017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057017.